Sector consensus Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 51.19 USD | +6.29% |
|
+2.38% | +16.21% |
| 09-15 | Scholar Rock Shares Fall After Barclays Downgrade | MT |
| 09-15 | Scholar Rock Faces Early Isembyld Launch Friction From FDA Safety Requirements, Truist Says | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 70.38 | +46.13% | 16 | ||||||
| 187.07 | +11.38% | 18 | ||||||
| 1,177.13 | +18.24% | 15 | ||||||
| 49.74 | +9.7% | 24 | ||||||
| 199.55 | +64.91% | 22 | ||||||
| 102.91 | +21.18% | 20 | ||||||
| 2,453.79 | +8.57% | 15 | ||||||
| 619.67 | +25.03% | 19 | ||||||
| 1,397.26 | +21.5% | 8 | ||||||
| 53.69 | -6.17% | 16 | ||||||
| 21.57 | +72.15% | 13 | ||||||
| 678.06 | +29.91% | 16 | ||||||
| 133.12 | +57.06% | 21 | ||||||
| 110 | +59.91% | 12 | ||||||
| 109.9 | +62.67% | 20 | ||||||
| 12.75 | +50.89% | 4 | ||||||
| 109 | +85% | 9 | ||||||
| 100.16 | +45.82% | 16 | ||||||
| 120.08 | +30.48% | 13 | ||||||
| 228.89 | +32% | 9 | ||||||
| Average | 396.74 | +37.32% | 15 | ||||||
| Weighted average by Cap. | 508.62 | +28.09% | 17 |
- Stock Market
- Stocks
- SRRK Stock
- Sector Scholar Rock Holding Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
